MEDICAL PRACTICE:

2008 - Current
  • Part time private medical practice, Hematology/Oncology
  • Teaching attending, Division of Hematology/Oncology,
  • St. Luke's Roosevelt Hospital Center, New York City, New York
2003 - 2007
  • Private medical practice, Hematology/Oncology,
  • Teaching attending, Division of Hematology/Oncology,
  • St. Luke's Roosevelt Hospital Center, New York City, New York
1993 - 2002
  • Private Medical practice, Hematology/Oncology, Atlantic County, New Jersey
1990 - 1993
  • Private Medical practice, Hematology/Oncology, King County, Washington

CLINICAL RESEARCH:

1/2010 - Current
  • Medical Director, Oncology Medical Affairs,
    Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
4/2008 - 12/2009
  • Senior Medical Director, Section Head Americas, i3 Research,
    Basking Ridge, New Jersey
1/2007- 4/2008
  • Associate Medical Director, Cancer Clinical Research,
    Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
4/2002- 9/2002
  • Assistant Medical Director, Oncology Clinical Development,
    Sanofi-Synthelabo Research, Malvern, Pennsylvania

HOSPITAL AFFILIATION:

2003 - Current
  • St. Luke’s Roosevelt Medical Center, New York, New York

EDUCATION:

1989 - 1990
  • Fellowship in Leukemia/Bone Marrow Transplantation, Hematology,
    Vancouver General Hospital, Vancouver, Canada
1988 - 1989
  • Fellowship in Medical Oncology & Hematology, Boston University Hospitals ,
    Boston, Massachusetts
1985 - 1988
  • Internal Medicine Residency, Atlantic City Medical Center,
    Atlantic City, New Jersey
1976 - 1983
  • Tehran University School of Medicine, Tehran, Iran - Degree: M.D.

CERTIFICATIONS:

May 2002
  • Recertified, American Board of Internal Medicine,
    Subspecialty: Medical Oncology
October 2001
  • Certified, European Society of Medical Oncology
October 1991
  • Diplomate, American Board of Internal Medicine,
    Subspecialty: Medical Oncology
September 1988
  • Diplomate, American Board of Internal Medicine

MEMBERSHIPS:
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Society for Blood and Marrow Transplantation
  • European Society for Medical Oncology

MEDICAL LICENSURE:
District of Columbia License No.: 16514
State of New Jersey License No.: MA 51788
State of Massachusetts License No.: 70486
State of Washington License No.: 252-09/0026466
New York State License No.: 227957

PUBLICATIONS:
  • Influence of post-Methotrexate folinic acid rescue on regimen related toxicity and raft-versus-host disease after allogeneic bone marrow transplantation.
    Bone Marrow Transplantation 1992, 9, 349-354.
  • Cyclosporine, Methotrexate and folinic acid rescue for prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Abstract, Blood supplement 1991.
  • Hemolytsis induced by anti-lymphocyte globulin in a patient with paroxysmal nocturnal hemoglobinuria. Abstract, Blood supplement 1991.
  • Reversible tricuspid regurgitation in a patient undergoing treatment for acute leukemia. Canadian Journal of Cardiology, Vol. 7, No 5, June 1991.